City Holding Co. Purchases 211 Shares of Danaher Co. (NYSE:DHR)

City Holding Co. boosted its holdings in shares of Danaher Co. (NYSE:DHR) by 2.1% during the first quarter, Holdings Channel reports. The institutional investor owned 10,268 shares of the conglomerate’s stock after acquiring an additional 211 shares during the quarter. City Holding Co.’s holdings in Danaher were worth $2,105,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Norges Bank acquired a new position in shares of Danaher in the 4th quarter worth approximately $2,130,740,000. GAMMA Investing LLC grew its position in Danaher by 24,958.2% in the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate’s stock valued at $383,524,000 after acquiring an additional 1,863,381 shares during the period. Raymond James Financial Inc. bought a new position in shares of Danaher during the fourth quarter valued at $391,172,000. Two Sigma Advisers LP boosted its stake in shares of Danaher by 4,248.8% in the 4th quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate’s stock valued at $376,347,000 after purchasing an additional 1,601,800 shares in the last quarter. Finally, Capital World Investors grew its holdings in shares of Danaher by 32.7% in the 4th quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate’s stock worth $1,460,215,000 after purchasing an additional 1,566,658 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of Danaher stock opened at $196.13 on Monday. Danaher Co. has a 12 month low of $171.00 and a 12 month high of $281.70. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $140.36 billion, a PE ratio of 37.15, a PEG ratio of 2.66 and a beta of 0.77. The stock’s fifty day simple moving average is $191.34 and its 200 day simple moving average is $212.03.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The business had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. On average, research analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.65%. Danaher’s payout ratio is presently 24.85%.

Wall Street Analyst Weigh In

DHR has been the subject of several analyst reports. Jefferies Financial Group cut their price target on shares of Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a report on Tuesday, April 22nd. Citigroup reaffirmed a “buy” rating on shares of Danaher in a report on Monday, April 7th. HSBC decreased their price target on Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. Guggenheim reissued a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, April 23rd. Finally, JPMorgan Chase & Co. lowered their target price on Danaher from $280.00 to $260.00 and set an “overweight” rating for the company in a research note on Tuesday, April 22nd. Five investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $263.24.

Insider Buying and Selling

In related news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction that occurred on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president now owns 15,179 shares of the company’s stock, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the company’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares of the company’s stock, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.